LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 6 of 497
Next
>>
>
126 to 150 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Dovitinib	0.04	uM	LJP5	3	E24	72	hr	1657	4591	5505	0.8339	0.7623
BT-20	Enzastaurin	0.04	uM	LJP5	1	D18	72	hr	1657	6094	5505	1.1069	1.1529
BT-20	Enzastaurin	0.04	uM	LJP5	2	D18	72	hr	1657	5924	5505	1.0760	1.1087
BT-20	Enzastaurin	0.04	uM	LJP5	3	D18	72	hr	1657	6352	5505	1.1537	1.2199
BT-20	Erlotinib	0.04	uM	LJP5	1	M24	72	hr	1657	4968	5505	0.9023	0.8603
BT-20	Erlotinib	0.04	uM	LJP5	2	M24	72	hr	1657	4512	5505	0.8195	0.7418
BT-20	Erlotinib	0.04	uM	LJP5	3	M24	72	hr	1657	4978	5505	0.9042	0.8629
BT-20	Foretinib	0.04	uM	LJP5	1	H12	72	hr	1657	5611	5505	1.0191	1.0274
BT-20	Foretinib	0.04	uM	LJP5	2	H12	72	hr	1657	5722	5505	1.0393	1.0562
BT-20	Foretinib	0.04	uM	LJP5	3	H12	72	hr	1657	5840	5505	1.0607	1.0869
BT-20	R406	0.04	uM	LJP6	1	C18	72	hr	1657	5469	5505	0.9933	0.9905
BT-20	R406	0.04	uM	LJP6	2	C18	72	hr	1657	5638	5505	1.0240	1.0344
BT-20	R406	0.04	uM	LJP6	3	C18	72	hr	1657	6329	5505	1.1495	1.2140
BT-20	Pictilisib	0.04	uM	LJP6	1	D24	72	hr	1657	4146	5505	0.7530	0.6467
BT-20	Pictilisib	0.04	uM	LJP6	2	D24	72	hr	1657	4782	5505	0.8686	0.8119
BT-20	Pictilisib	0.04	uM	LJP6	3	D24	72	hr	1657	4300	5505	0.7810	0.6867
BT-20	Gefitinib	0.04	uM	LJP6	1	N12	72	hr	1657	5726	5505	1.0400	1.0573
BT-20	Gefitinib	0.04	uM	LJP6	2	N12	72	hr	1657	5769	5505	1.0478	1.0684
BT-20	Gefitinib	0.04	uM	LJP6	3	N12	72	hr	1657	5792	5505	1.0520	1.0744
BT-20	Geldanamycin	0.04	uM	LJP5	1	O06	72	hr	1657	2426	5505	0.4406	0.1997
BT-20	Geldanamycin	0.04	uM	LJP5	2	O06	72	hr	1657	2985	5505	0.5422	0.3449
BT-20	Geldanamycin	0.04	uM	LJP5	3	O06	72	hr	1657	2527	5505	0.4590	0.2259
BT-20	Geldanamycin	0.04	uM	LJP6	1	O06	72	hr	1657	2544	5505	0.4621	0.2303
BT-20	Geldanamycin	0.04	uM	LJP6	2	O06	72	hr	1657	2857	5505	0.5189	0.3117
BT-20	Geldanamycin	0.04	uM	LJP6	3	O06	72	hr	1657	2708	5505	0.4919	0.2729

|<
<<
Previous
Page 6 of 497
Next
>>
>
126 to 150 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)